FATAL FULMINANT INFLUENZA A MYOCARDITIS

SUMMARY
Introduction. Myocarditis is defined as an inflammation of a heart muscle, which can be caused by a number of agents, among which viruses are the most common. Fulminant myocarditis is a rapidly progressive, life-threatening myocarditis, followed by the development of cardiogenic shock. Among viruses, there are a number of common ones, but according to our knowledge, there are only a few cases of fulminant myocarditis caused by Influenza A virus described in the literature.
Case report. We present a case of a 44 year-old man who was admitted to the Cardiology Intensive Care Unit because of the clinical as well as electrocardiographic signs pointing to the ST segment elevated myocardial infarction with peracute development of heart failure and cardiogenic shock and subsequently lethal outcome, despite applied circulatory support. Urgent coronarography showed no signs of coronary artery disease, while the autopsy revealed myocarditis and real-time PCR of nasopharyngeal swab revealed Influenza A H3 virus.
Conclusion. Fulminant myocarditis is a life-threatening cardiac disease which should be treated in the Intensive Care Units with both medicament and mechanical circulatory support and antiviral therapy and which, despite applied therapy, has a high mortality rate. Based on echocardiography, one of the proposed diferential diagnosis, acute pulmonary thromboembolism, was excluded. The possible other three diferential diagnosis were acute myocardial infarction, early phase of acute lung injury -pneumonia and myocarditis as well.
Immediately after admission, in order to exclude acute myocardial infarction, transradial coronary angiography was performed, with only 30 cc of contrast media and with no complications and hemodynamic compromise during the procedure. It showed normal finding ( Figure 2 ).
During the first two hours after admission to the Cardiology Intensive Care Unit the patient was conscious, breathing spontaneously using oxygen supplementation, normotensive (systolic pressure 110-130 mmHg ), tachycardic (100-120 beats per minute), and afebrile.
Due to symptoms and signs of acute heart failure, furosemid and nitroglicerin infusion (5 mcg/min) was administered with continuous invasive arterial monitoring via left radial artery.
Laboratory tests showed elevated levels of Troponin I, N-terminal Brain-Type Natriuretic
Peptide and C-reactive protein ( Table 1 ). There were no other specific abnormalities in laboratory findings ( Table 1 and 2). Chest X-ray showed emphasized right pulmonary hilum and a stricter bronchovascular drawing ( Figure 3 ).
During that time echocardiography in the Cardiology Intensive Care Unit as well as coronary angiography were performed.
During the third hour of hospitalization, there was a rapid progression of antegrade heart failure with the rapid evolution to cardiogenic shock. The patient became hypotensive (70/40mmHg) and extremely dyspnoic, with low urine output (less then 0.5 ml/kg/hour).
Fluid challenge of 250 ml of 0.9% sodium chloride was performed without adequate response, so inotropic and vasopresor stimulation was applied. Due to rapid respiratory failure immediately afterwards endotracheal intubation was performed and the patient was artificially ventilated. Bicarbonates were applied according to the blood gas analyses.
Despite artificial ventilation and high inotropic (Dobutamin of 10 mg/kg/min) and vasopressor (Norepinephrine of 1.8 ug/kg/min) support, there was no improvement of hemodynamic status of the patient. Furthermore, the patient was markedly hypotensive with mean arterial pressure not exceeding 50 mmHg. Deterioration of arterial blood gas analysis was noticed as well, with high lactate levels (lactate of 9.1 mmol/l).
To evaluate the cause of rapid and refractory cardiogenic shock, bedside echocardiography was repeated, and decreasing of global contractility was noticed (EF estimated of 20%), no Real-time PCR of the nasopharyngeal swab was Influenza A (H1N1) negative, but Influenza A (H3) positive (Table 3) .
On autopsy, the macroscopic pathohistological analysis showed the globally slightly dilated heart, weighted 410g. Coronary arteries were slightly atherosclerotic without significant stenosis. Myocardium was pale, grayish, softened, and thin, with focal small dotty hemorrhages. No signs of previous or new ischemic lesions.
Microscopic pathohistological analysis revealed myocardium infiltrated with dense inflammatory lymphocyte infiltrate, rare neutrophile and rare eosinophile granulocytes and histiocytes with focal areas of necrotic cardiomyocytes and extensive interstitial edema (Figure 4-6 ). Pulmonary histopathological findings revealed thickened alveolar walls, interstitial edema and alveolar lumen filled with transudate -the picture of cardiogenic pulmonary edema. (Figure 7-8) 
DISCUSSION
Fulminant myocarditis is a rapidly progressive, life-threatening myocarditis, followed by the development of cardiogenic shock [7, 8] .
Precise incidence of myocarditis is difficult to evaluate and according to some data it has been about 8 to 10 per 100 000 population. Pathologic series of Fabre and Sheppard showed that inflammatory disorders including lymphocytic myocarditis and cardiac sarcoidosis account for 8.6% of all sudden adult cardiac deaths [4] .
Viruses are the most common cause of myocarditis. Among viruses, the most common are enteroviruses including coxsackie virus, adenovirus, parvovirus, hepatitis C virus, human immunodeficiency virus, while other viruses, such as influenza A virus, rarely cause myocarditis. Recently, by using modern molecular methods, simultaneous presence of more viral antigens is discovered. These viruses possibly strengthen the virulence of one another, but a genetic defect in human immune system which leads to incapability to destroy multiple viral forms is possible, as well [9, 10] .
It is shown that during influenza epidemics, 5 to 10% of infected patients may have cardiac symptoms [2] . Patients with fulminant myocarditis often have flu-like symptoms for 2-4 weeks prior cardiac presentation. Physical examination at the time of presentation to the Intensive Care Unit shows NYHA class III or IV heart failure symptoms, hypotension, tachycardia, livid cold extremities, hemodynamic instability and respiratory failure [2] .
In our case report, flu like symptoms (cough and sweating) were present 4 days prior admission. However, body temperature was normal. To make diagnosis even more difficult to establish, a short loss of consciousness was the main reason for the doctor's attention. In physical finding, heart failure symptoms and signs of heart failure Killip class II/III were present.
At the time of admission, proposed differential diagnosis were acute pulmonary thromboembolism, acute myocardial infarction with heart failure, acute lung injury and fulminant myocarditis.
Initial laboratory tests usually show elevated inflammatory markers (erytrocyte sedimentation rate and reactive C protein), however they do not confirm the diagnosis and are often increased in other circumstances such as acute pericarditis [11] .
Despite that cardiac troponins are more sensitive of myocyte injury than creatine kinase enzyme, they are not specific for myocarditis, and when normal do not exclude myocarditis. Brain natriuretic peptides and circulating cytokines are non-specific for myocarditis, as well [12, 13] .
Current ESC guidelines strongly recommend assessement of Troponins, erythrocyte sedimentation rate, reactive C protein levels in all patients while routine viral serology testing is not recommended [14] . Except slightly elevation of Tn I (0.16 mg/l), NT pro BNP (1550 pg/ml) and CRP (7.7 mg/l), there were no other specific abnormalities in our patient laboratory at admission. This is also a confirmation of severe and rapidly progressive form of fulminant myocarditis.
Electrocardiograhic abnormalities range from T wave inversion to ST segment elevation, as
well as disorders in intraventricular conduction (wide QRS complex), and both supraventricular and ventricular arrhythmias. However, ECG signs are neither specific nor sensitive for myocarditis [15] . In combination with elevated cardiac enzymes and echocardiography finding, the suspicion of acute myocardial infarction as differential diagnosis could be established as well.
Echocardiography is the first choice imaging technique in evaluation of cardiac function.
According to the study of Felker and colleagues, among the patients with fulminant myocarditis, echocardiogram usually shows low ejection fraction, normal end-diastolic diameter of left ventricle and increased left ventricle wall thickness due to inflammatory response resulting in interstitial oedema [16] . In our report, bedside echocardiography at first showed slightly decreased global contractility (EF of 45%) with rapid progression of myocardial function and three hours after admission ejection fraction was estimated to 20%.
Coronary angiography is recommended among all adult patients in order to exclude thrombosis of epicardial coronary artery and it is extremely important among patients with known risk factors for coronary disease.
Cardiac magnetic resonance (MRI) is considered as the most sensitive non-invasive imaging method for diagnostics of myocarditis, showing subepicardial late enhancement pattern, there by visualizing myocarditis-related necrosis [17] . Cardiac MRI findings consistent with myocarditis should be based on Lake-Louise criteria [18] .
However, most of the patients with fulminant myocarditis are hemodinamically unstable and therefore MRI is not possible. In our report, clinical deterioration was so rapid, that performing MRI could not be done.
Furthermore, cardiac MRI cannot replace endomyocardial biopsy.
Endomyocardial biopsy (EMB) and pathohistological analysis has a critical role in evaluation of the patients with unexplainable acute heart failure and it has ACC/AHA class I indication in evaluation of hemodynamically unstable patients with cardiac insufficiency lasting less than two weeks, with optimal sensitivity as soon as symptoms started [2] .
Intensive myocardial inflammation with cardiomyocite necrosis is pathological, but it is nonspecific sign of fulminant myocarditis. Histological findings can be classified according to the Dallas criteria as active myocarditis, borderline myocarditis and negative. Despite being a gold standard for unequivocal diagnosis of myocarditis, there are a number of reasons for insensitivity of Dallas criteria [17, 19] .
Myocardial samples, each 1 -2 mm in size, taken from EMB should be analysed using histology, immunohistochemistry, and viral PCR. High quality EMB confirms the diagnosis of myocarditis, identifies the underlying aetiology and the type of inflammation (e.g. giant cell, eosinophilic myocarditis, sarcoidosis), and therefore can guide different treatments and predict prognosis [14] . There is no specific therapy of fulminant myocarditis. Since the patients are usually hemodynamically unstable, supportive therapy is used as the first choice of therapy. In our report, endotracheal intubation, inotropic and vasopresor support were the first line of therapy. However, the result of supportive measures was very poor. There was also lack of time to implant IABP as a second line therapy, mainly due to highly progressive cardiogenic shock with subsequent cardiac arrest.
Despite intensive treatment, the mortality associated with fulminant myocarditis is high, from 39% for patients with fulminant myocarditis associated with the H1N1 reported by 
